- Home
- TCMD vs KIO Comparison
TCMD vs KIO Comparison
Compare TCMD & KIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TCMD | KIO |
|---|---|---|
| Founded | 1995 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 533.5M | 461.1M |
| IPO Year | 2016 | 2011 |
Fundamental Metrics
Financial Performance| Metric | TCMD | KIO |
|---|---|---|
| Price | $28.22 | $11.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $36.00 | N/A |
| AVG Volume (30 Days) | 203.2K | ★ 211.2K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.14 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.60 | N/A |
| Revenue Next Year | $9.14 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.60 | $10.65 |
| 52 Week High | $37.77 | $12.83 |
Technical Indicators
Market Signals| Indicator | TCMD | KIO |
|---|---|---|
| Relative Strength Index (RSI) | 44.58 | 36.98 |
| Support Level | $27.12 | $10.92 |
| Resistance Level | $27.67 | $11.25 |
| Average True Range (ATR) | 1.18 | 0.12 |
| MACD | -0.33 | -0.03 |
| Stochastic Oscillator | 13.74 | 11.16 |
Price Performance
Historical ComparisonAbout TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
About KIO KKR Income Opportunities Fund
KKR Income Opportunities Fund operates as a closed-end registered management investment company. The Fund's main objective is to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in a portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.